EBR Article: Harnessing Hybrids
The October 2017 issue of European Biopharmaceutical Review (EBR) covers several new medical innovations, especially within the research fields of oncology and stem cell therapies. Formulation and quality control is another key focus topic, with content on screening designs and mycoplasma contamination. EBR Industry Advisor Jon Weisberg has provided a special feature on the potential effects of the EU General Data Protection Regulation, based on expert views collected at DIA 2017.
Click here to read the featured article on 'hybrid' LC-MS assays
You can read the October issue in full by visiting the EBR website.